A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy
Tohru Nakagawa(Sapporo Kosei General Hospital), Robert B. Jenkins(Dartmouth–Hitchcock Medical Center)
Cited by 180
Related Papers
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
|Journal of Clinical Oncology|2006|725
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
|PLoS ONE|2013|663
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
|Journal of Clinical Oncology|2008|275
Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer
|Journal of Clinical Oncology|2001|264